No Data
No Data
Should You Consider Adding Clarivate Plc (CLVT) to Your Portfolio?
Clarivate Reveals First Year of Unitary Patent Court Litigation Activity
Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today launched the report One year later in the UPC: First...
Clarivate Plc's (NYSE:CLVT) Popularity With Investors Is Under Threat From Overpricing
With a median price-to-sales (or "P/S") ratio of close to 1.3x in the Professional Services industry in the United States, you could be forgiven for feeling indifferent about Clarivate Plc's (NYSE:CL
Express News | Clarivate PLC : Oppenheimer Cuts Target Price to $9 From $10
Oppenheimer Trims Price Target on Clarivate to $9 From $10, Maintains Outperform Rating
Clarivate (CLVT) has an average rating of outperform and price targets ranging from $6 to $10, according to analysts polled by Capital IQ. Price: 5.60, Change: +0.04, Percent Change: +0.72
JAAD RANKS NO. 1 AMONG DERMATOLOGY JOURNALS
The Journal of the American Academy of Dermatology's impact factor remains #1 in field ROSEMONT, Ill. , July 2, 2024 /PRNewswire/ -- The Journal of the American Academy of Dermatology remains the top